PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $351,000 | +0.6% | 142,162 | +0.6% | 0.00% | – |
| Q4 2020 | $349,000 | -41.3% | 141,325 | -25.2% | 0.00% | – |
| Q3 2020 | $595,000 | -26.8% | 188,992 | -32.4% | 0.00% | -100.0% |
| Q2 2020 | $813,000 | -20.0% | 279,373 | -22.4% | 0.00% | 0.0% |
| Q1 2020 | $1,016,000 | -43.0% | 360,230 | -34.4% | 0.00% | 0.0% |
| Q4 2019 | $1,781,000 | +23.4% | 548,956 | -17.8% | 0.00% | 0.0% |
| Q3 2019 | $1,443,000 | -48.6% | 668,080 | -25.3% | 0.00% | -50.0% |
| Q2 2019 | $2,809,000 | -33.4% | 894,675 | -21.1% | 0.00% | -50.0% |
| Q1 2019 | $4,220,000 | +23.5% | 1,134,451 | -3.7% | 0.00% | +33.3% |
| Q4 2018 | $3,417,000 | +8.7% | 1,178,156 | -1.4% | 0.00% | 0.0% |
| Q3 2018 | $3,144,000 | +3.3% | 1,195,456 | -8.1% | 0.00% | 0.0% |
| Q2 2018 | $3,044,000 | -39.8% | 1,300,877 | -24.3% | 0.00% | -40.0% |
| Q1 2018 | $5,055,000 | -2.9% | 1,719,285 | -9.6% | 0.01% | 0.0% |
| Q4 2017 | $5,208,000 | -10.9% | 1,900,871 | +10.3% | 0.01% | -16.7% |
| Q3 2017 | $5,844,000 | +32.9% | 1,723,944 | -3.2% | 0.01% | +20.0% |
| Q2 2017 | $4,398,000 | +19.0% | 1,780,394 | +9.4% | 0.01% | -16.7% |
| Q1 2017 | $3,696,000 | +8.0% | 1,628,158 | +0.9% | 0.01% | +20.0% |
| Q4 2016 | $3,422,000 | -54.9% | 1,614,119 | -28.7% | 0.01% | -54.5% |
| Q3 2016 | $7,582,000 | +13.1% | 2,263,411 | +6.0% | 0.01% | 0.0% |
| Q2 2016 | $6,704,000 | -1.8% | 2,134,981 | +4.1% | 0.01% | 0.0% |
| Q1 2016 | $6,829,000 | +60.2% | 2,050,819 | +70.3% | 0.01% | +57.1% |
| Q4 2015 | $4,264,000 | -9.8% | 1,204,436 | +28.2% | 0.01% | -22.2% |
| Q3 2015 | $4,727,000 | +8.3% | 939,835 | +38.5% | 0.01% | 0.0% |
| Q2 2015 | $4,365,000 | +28.3% | 678,810 | +40.4% | 0.01% | +28.6% |
| Q1 2015 | $3,402,000 | +31.1% | 483,616 | +43.7% | 0.01% | +40.0% |
| Q4 2014 | $2,595,000 | -23.5% | 336,565 | -25.9% | 0.01% | -37.5% |
| Q3 2014 | $3,392,000 | -23.2% | 454,109 | -0.4% | 0.01% | -20.0% |
| Q2 2014 | $4,415,000 | +28.5% | 456,123 | +10.4% | 0.01% | +25.0% |
| Q1 2014 | $3,435,000 | -5.7% | 413,314 | -4.3% | 0.01% | -11.1% |
| Q4 2013 | $3,644,000 | +3.7% | 431,780 | -2.1% | 0.01% | -10.0% |
| Q3 2013 | $3,514,000 | +21.8% | 440,863 | +18.0% | 0.01% | +25.0% |
| Q2 2013 | $2,885,000 | – | 373,658 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |